Topic

Management of Multi-Drug Resistant TB Report essay

Instructions

You will be required to write a 2500-word evidence-based, referenced report on the management of multi-drug resistant TB. This should include a critical analysis of the current evidence available for the pharmacological treatment of that disease and the comparative weight of evidence for demand. You will be required to provide written guidance to a formulary committee on where delamanid could or should be considered in this setting including a treatment regimen. The report should conclude with your recommendations for treatment supported by the relevant published literature (The literature reviewed may also include unpublished study information/grey literature).

Answer Preview

Multi-drug resistant tuberculosis is a health issue that is increasingly becoming a global menace. Tuberculosis (TB) is a bacterial disease that is caused by Mycobacterium tuberculosis, which mostly affects the lungs (WHO, 2016). About 30% of the global population has latent TB, with a 10% chance of getting ill. Approximately 49 million people were saved from TB, through effective treatment between 2000 and 2015. MDR-TB is a form of TB that is caused by bacteria strains that resist anti-TB drugs, especially the two most powerful, first-line drugs,

Word Count: 3600